Novus Acquisition & Development Corp. announced earnings results for the second quarter and six months ended June 30, 2017. For the quarter, revenue increased by 121% to $31,094 as compared to the three months ended June 30, 2016. This increase was primarily due to increased awareness and visibility of the Novus MedPlan offering and the improvement in key performance indicators (KPI) in the company's in-house marketing efforts, which resulted in a great number of lives covered. Operating and net income increased by almost 10-fold to $11,448 for the three months ended June 30, 2017, as compared to the three months ended June 30, 2016. This represents a 37% operating profit margin for the three months ended June 30, 2017. For the six months, revenue increased by 76% to $58,318 as compared to the six months ended June 30, 2016. This increase was primarily due to increased awareness and visibility of the Novus MedPlan offering and the improvement in key performance indicators (KPI) in the company's in-house marketing efforts, which resulted in a great number of lives covered. Operating and net income increased by 287% to $21,282 as compared to the six months ended June 30, 2016. This represents a 36% operating profit margin for the six months ended June 30, 2017.